Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 26.90
+0.11 (0.41%)
Sep 18, 2025, 3:04 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Antihypertensive Active Pharmaceutical Ingredients and Intermediates | 1.44B | Log In | Log In | Log In | Log In | Upgrade |
Antihypertensive Active Pharmaceutical Ingredients and Intermediates Growth | -11.70% | Log In | Log In | Log In | Log In | Upgrade |
Blood Sugar Lowering Active Pharmaceutical Ingredients and Intermediates | 272.93M | Log In | Log In | Log In | Log In | Upgrade |
Blood Sugar Lowering Active Pharmaceutical Ingredients and Intermediates Growth | 211.23% | Log In | Log In | Log In | Log In | Upgrade |
Anticoagulant Active Pharmaceutical Ingredients and Intermediates | 270.83M | Log In | Log In | Log In | Log In | Upgrade |
Anticoagulant Active Pharmaceutical Ingredients and Intermediates Growth | -22.71% | Log In | Log In | Log In | Log In | Upgrade |
Preparations | 254.76M | Log In | Log In | Log In | Log In | Upgrade |
Anti-asthma Active Pharmaceutical Ingredients and Intermediates | 203.59M | Log In | Log In | Log In | Log In | Upgrade |
Anti-asthma Active Pharmaceutical Ingredients and Intermediates Growth | 20.04% | Log In | Log In | Log In | Log In | Upgrade |
Lipid-lowering Active Pharmaceutical Ingredients and Intermediates | 99.62M | Log In | Log In | Log In | Log In | Upgrade |
Lipid-lowering Active Pharmaceutical Ingredients and Intermediates Growth | 69.57% | Log In | Log In | Log In | Log In | Upgrade |
Other | 92.18M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -51.07% | Log In | Log In | Log In | Log In | Upgrade |
Antiviral Active Pharmaceutical Ingredients and Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Antiviral Active Pharmaceutical Ingredients and Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Manufacturing Organization | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Manufacturing Organization Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 92.18M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -51.07% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
China | 2.63B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 4.10% | Log In | Log In | Log In | Log In | Upgrade |